Loading your page…
Marketing-authorisation holder · Germany
14 medicines in 4 countries, as authorisation holder, manufacturer and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EPRUVYSoluzione iniettabile | Ranibizumab | Italy | Authorised | |
| Epruvy 10 mg/ml oplossing voor injectieOplossing voor injectie | Ranibizumab | Netherlands | Authorised | 2024 |
| Epruvy (previously Ranibizumab Midas) | Ranibizumab | EU (EMA) | Authorised | 2024 |
| RANIVISIOSoluzione iniettabile | Ranibizumab | Italy | Authorised | |
| Ranivisio | Ranibizumab | EU (EMA) | Authorised | 2022 |
| Ranivisio 10 mg/ml, oplossing voor injectieOplossing voor injectie | Ranibizumab | Netherlands | Authorised | 2022 |
| RANIVISIO 10 MG/ML SOLUCION INYECTABLE10 mg · Solución inyectable | Ranibizumab | Spain | Marketed | 2022 |
| RANIVISIO 10 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA10 mg/ml · Solución inyectable en jeringa precargada | Ranibizumab | Spain | Authorised | 2025 |
| Tranexaminezuur Midas 1000 mg, omhuld granulaat in sachetOmhuld granulaat | Tranexamic acid | Netherlands | Authorised | 2026 |
| TRICUAL 10 MG/5 MG/5 MG COMPRIMIDOS5 mg + 6,94 mg + 10,85 mg · Comprimido | Ramipril, Amlodipine, Atorvastatin | Spain | Authorised | 2024 |
| TRICUAL 20 MG/10 MG/10 MG COMPRIMIDOS10 mg + 13,88 mg + 21,70 mg · Comprimido | Ramipril, Amlodipine, Atorvastatin | Spain | Authorised | 2024 |
| TRICUAL 20 MG/5 MG/10 MG COMPRIMIDOS10 mg + 6,94 mg + 21,70 mg · Comprimido | Ramipril, Amlodipine, Atorvastatin | Spain | Authorised | 2024 |
| TRICUAL 20 MG/5 MG/5 MG COMPRIMIDOS5 mg + 6,94 mg + 21,7 mg · Comprimido | Ramipril, Amlodipine, Atorvastatin | Spain | Authorised | 2024 |
| TRICUAL 40 MG/10 MG/10 MG COMPRIMIDOS10 mg + 13,88 mg + 43,40 mg · Comprimido | Ramipril, Amlodipine, Atorvastatin | Spain | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 7 | 7 | 0 | CompaniesAll medicines |
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
| Italy | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
